1. Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study
   Marwan S.M. Al-Nimer et al, 2019, Electronic Journal of General Medicine CrossRef
2. The Effect of Combined Antihypertensive Therapy on the Morning Blood Pressure. The Results of a Single-Center Study RANOK.2.0
   Л.В. Распутина et al, 2021, Кардиология в Беларуси CrossRef
3. Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia
   Chen-Hung Lee et al, 2021, Pharmaceutics CrossRef
4. ChaiQi Decoction Alleviates Vascular Endothelial Injury by Downregulating the Inflammatory Response in ApoE-Model Mice
   Bingran Wang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Dynamics of endocrine and metabolic changes among patients with coronary artery disease, type 2 diabetes mellitus and metabolic syndrome while treating with telmisartan
   N.V. Chmyr, 2022, INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) CrossRef
6. Hybrid Core–Shell Nanofibrous Scaffolds/Stents Deliver Angiotensin II Receptor Blocker to Treat Diabetic Artery Disease
   Chen-Hung Lee et al, 2022, ACS Applied Polymer Materials CrossRef
7. PECULIARITIES OF CARBOHYDRATE METABOLISM INDICATORS, THE FUNCTIONAL STATE OF THE THYROID GLAND IN THE COURSE TREATMENT WITH TELMISARTAN AS PART OF THE COMPLEX THERAPY OF PATIENTS WITH CORONARY ARTERY DISEASE, TYPE 2 DIABETES MELLITUS ON THE BASIS OF METAB
   Nataliya Chmyr et al, 2023, Acta Medica Leopoliensia CrossRef